Literature DB >> 33946584

CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma.

Lisa Frey1, Niklas Klümper1, Doris Schmidt1, Glen Kristiansen2, Marieta Toma2, Manuel Ritter1, Abdullah Alajati1, Jörg Ellinger1.   

Abstract

BACKGROUND: Circular RNA (circRNA) plays an important role in the carcinogenesis of various tumors. It is assumed that circRNAs have a high tissue and tumor specificity, thus they are discussed as cancer biomarkers. The knowledge about circRNAs in clear cell renal carcinoma (ccRCC) is limited so far, and thus we studied the expression profile of seven circRNAs (circCOL5A1, circEHD2, circEDEM2, circEGNL3, circNETO2, circSCARB1, circSOD2) in a cohort of ccRCC patients.
METHODS: Fresh-frozen normal and cancerous tissues were prospectively collected from patients with ccRCC undergoing partial/radical nephrectomy. Total RNA was isolated from 121 ccRCC and 91 normal renal tissues, and the circRNA expression profile was determined using quantitative real-time PCR.
RESULTS: circEHD2, circENGLN3, and circNETO2 were upregulated in ccRCC compared with non-malignant renal tissue. circENGLN3 expression was highly discriminative between normal and cancerous tissue. None of the circRNAs was correlated with clinicopathological parameters. High circEHD2 and low circNETO2 levels were an independent predictor of a shortened progression-free survival, cancer-specific survival, and overall survival in patients with ccRCC undergoing nephrectomy.
CONCLUSIONS: The analysis of circRNAs may provide diagnostic and prognostic information. Thus, circRNAs could help to optimize the individual treatment and ultimately improve ccRCC patients' survival.

Entities:  

Keywords:  biomarker; circEGLN3; circEHD2; circNETO2; circular RNA; renal cell carcinoma

Year:  2021        PMID: 33946584     DOI: 10.3390/cancers13092177

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  21 in total

1.  Comprehensive characterization of tissue-specific circular RNAs in the human and mouse genomes.

Authors:  Siyu Xia; Jing Feng; Lijun Lei; Jun Hu; Linjian Xia; Jun Wang; Yu Xiang; Lingjun Liu; Shan Zhong; Leng Han; Chunjiang He
Journal:  Brief Bioinform       Date:  2017-11-01       Impact factor: 11.622

2.  Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  B Escudier; C Porta; M Schmidinger; N Rioux-Leclercq; A Bex; V Khoo; V Gruenvald; A Horwich
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

3.  Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.

Authors:  Dong Zhang; Xiao-Jie Yang; Qi-Dong Luo; De-Lai Fu; Zhao-Lun Li; Peng Zhang; Tie Chong
Journal:  Am J Pathol       Date:  2019-08-30       Impact factor: 4.307

4.  CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis.

Authors:  Jijian Sun; Shijie Pan; Hongquan Cui; Hao Li
Journal:  Curr Cancer Drug Targets       Date:  2020       Impact factor: 3.428

5.  CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs.

Authors:  Dawood B Dudekula; Amaresh C Panda; Ioannis Grammatikakis; Supriyo De; Kotb Abdelmohsen; Myriam Gorospe
Journal:  RNA Biol       Date:  2016       Impact factor: 4.652

6.  CSCD: a database for cancer-specific circular RNAs.

Authors:  Siyu Xia; Jing Feng; Ke Chen; Yanbing Ma; Jing Gong; Fangfang Cai; Yuxuan Jin; Yang Gao; Linjian Xia; Hong Chang; Lei Wei; Leng Han; Chunjiang He
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

7.  MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.

Authors:  Ying Zhang; Lu Guo; Yuhuan Li; Gui-Hai Feng; Fei Teng; Wei Li; Qi Zhou
Journal:  Mol Cancer       Date:  2018-01-05       Impact factor: 27.401

8.  Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells.

Authors:  Leilei Zhang; Jinlong Li; Dan Tian; Lihua Sun; Xu Wang; Miao Tian
Journal:  Cell Death Dis       Date:  2020-01-02       Impact factor: 8.469

Review 9.  The significance of exosomes in the development and treatment of hepatocellular carcinoma.

Authors:  Xin Li; Chuanyun Li; Liping Zhang; Min Wu; Ke Cao; Feifei Jiang; Dexi Chen; Ning Li; Weihua Li
Journal:  Mol Cancer       Date:  2020-01-04       Impact factor: 27.401

10.  Circular RNA microarray expression profile and potential function of circ0005875 in clear cell renal cell carcinoma.

Authors:  Qi Lv; Chunhui Ma; Haoming Li; Xuefeng Tan; Gangmin Wang; Yinan Zhang; Peijun Wang
Journal:  J Cancer       Date:  2020-10-18       Impact factor: 4.207

View more
  8 in total

1.  Circular RNAs as Prognostic Biomarkers in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Dan Liao; Qiu Lin; Huan Xiao; Fenglian Zhang; Qin Han
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

Review 2.  CircRNAs as Novel Biomarkers and Therapeutic Targets in Renal Cell Carcinoma.

Authors:  Yuxia Zhou; Cheng Li; Zhenping Wang; Shuangfeng Tan; Yiqi Liu; Hu Zhang; Xuefeng Li
Journal:  Front Mol Biosci       Date:  2022-02-11

3.  Decreased Expression of circ_0000160 in Breast Cancer With Axillary Lymph Node Metastasis.

Authors:  Ya-Wen Wang; Xu Chen; Yaru Tian; Long Liu; Peng Su
Journal:  Front Mol Biosci       Date:  2022-02-08

4.  Systematic Review With Meta-Analysis: Diagnostic, Prognostic and Clinicopathological Significance of CircRNA Expression in Renal Cancer.

Authors:  Wujun Wang; Shengfang Xie; Dongping Yuan; Dandan He; Liming Fang; Fengfeng Ge
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

5.  Circular RNA Eps15-homology domain containing protein 2 motivates proliferation, glycolysis but refrains autophagy in non-small cell lung cancer via crosstalk with microRNA-3186-3p and forkhead box K1.

Authors:  Fan Zhang; Tieying Zhang; ZiRan Zhao; Ying Ji; Yue Peng; Liang Zhao
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

6.  Circular RNA Eps15-homology domain-containing protein 2 induce resistance of renal cell carcinoma to sunitinib via microRNA-4731-5p/ABCF2 axis.

Authors:  Wen Li; GaiXia Li; LuQuan Cao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 7.  Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma.

Authors:  Sina Rashedi; Mahta Mardani; Ali Rafati; Mohammad Mahdi Khavandi; Fatemeh Mohammadi; Salar Javanshir; Rojin Sarallah; Mahsa Dolatshahi; Mohammadmahdi Sabahi; Sina Azadnajafabad; Hamed Tavolinejad; Nima Rezaei
Journal:  J Clin Lab Anal       Date:  2022-08-21       Impact factor: 3.124

Review 8.  Circular RNA-Is the Circle Perfect?

Authors:  Lavinia Caba; Laura Florea; Cristina Gug; Daniela Cristina Dimitriu; Eusebiu Vlad Gorduza
Journal:  Biomolecules       Date:  2021-11-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.